|
|
|
|
| LEADER |
01000caa a22002652 4500 |
| 001 |
CTG004593146 |
| 003 |
DE-627 |
| 005 |
20230425170347.0 |
| 007 |
cr uuu---uuuuu |
| 008 |
210507s2023 xx |||||o 00| ||dut c |
| 035 |
|
|
|a (DE-627)CTG004593146
|
| 035 |
|
|
|a (UBBS_Klinische_Studien_WHO)NTR6309
|
| 035 |
|
|
|a (UBBS_Klinische_Studien_WHO)NL6162
|
| 035 |
|
|
|a (UBBS_Klinische_Studien_WHO)NL58563.078.16
|
| 035 |
|
|
|a (UBBS_Klinische_Studien_WHO)OZBS72.15181
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a dut
|
| 245 |
1 |
0 |
|a Het nut van driedimensionale virtual reality echoscopie tijdens de eerste drie maanden van de zwangerschap
|b Virtual Reality & Feasibility and Efficacy of first Trimester Ultrasound: a randomized controlled trial
|
| 264 |
|
1 |
|c 2023
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a Computermedien
|b c
|2 rdamedia
|
| 338 |
|
|
|a Online-Ressource
|b cr
|2 rdacarrier
|
| 500 |
|
|
|a WHO International Clinical Trials Registry Platform (https://www.who.int/ictrp/en/), First posted: 2017-01-26, Last updated: 2023-04-06
|
| 650 |
|
4 |
|a Medical Condition: Women with a first trimester pregnancy at risk for a child with a congenital anomaly (=i.e. a high risk pregnancy). A high risk pregnancy means that there is an increased risk of the development of an anomaly in any of the fetal organ systems; for example the brain, skull, face, abdominal wall, thorax, extremities, skeleton, heart, neural tube, kidneys, placenta, amniotic fluid, umbilical cord and an increased thickness of the nuchal fold, when compared to the general population. Key words: 3D ultrasound, virtual reality, first trimester anomaly scan
|
| 650 |
|
4 |
|a Study Type: Interventional
|
| 650 |
|
4 |
|a Recruitment Status: Completed
|
| 650 |
|
4 |
|a 610
|
| 773 |
0 |
8 |
|i Enthalten in
|t WHO International Clinical Trials Registry Platform
|g (2023) vom: 03. Apr.
|
| 773 |
1 |
8 |
|g year:2023
|g day:03
|g month:04
|
| 856 |
4 |
0 |
|u https://www.onderzoekmetmensen.nl/en/trial/28245
|z kostenfrei
|3 Volltext
|
| 912 |
|
|
|a GBV_CTG
|
| 912 |
|
|
|a SSG-OLC-PHA
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|j 2023
|b 03
|c 04
|
Klinische Studie